Table 6 Indications for operations in women with elective CSs
Indication | Absolute contribution to the CS rate in group 2B, %, 2014 | Absolute contribution to the CS rate in group 2B, %, 2016 | p value | Absolute contribution to the overall CS rate, %, 2014 | Absolute contribution to the overall CS rate, %, 2016 | p value |
|---|---|---|---|---|---|---|
Placental and umbilical cord pathology | 10.4 11/106 | 4.9 4/82 | p = 0.168 | 0.3 11/3502 | 0.1 4/3526 | p = 0.069 |
Fetus related conditions | 11.3 12/106 | 15.9 13/82 | p = 0.363 | 0.3 12/3502 | 04 13/3526 | p = 0.857 |
Maternal diseases | 49.0 52/106 | 61.0 50/82 | p = 0.103 | 1.5 52/3502 | 1.4 50/3526 | p = 0.667 |
Suspected fetal macrosomia | 9.4 10/106 | 4.9 4/82 | p = 0.238 | 0.3 10/3502 | 0.1 4/3526 | p = 0.105 |
Preeclampsia | 4.7 5/106 | 7.3 6/82 | p = 0.453 | 0.1 5/3502 | 0.2 6/3526 | p = 0.772 |
Post-term pregnancy | 15.1 16/106 | 6.1 5/82 | p = 0.052 | 0.5 16/3502 | 0.1 5/3526 | p = 0.016 |
Total | 3.0106/3502 | 2.3 82/3526 | p = 0.069 |